I have just returned from an event in France which, I have to say, really impressed me. Not because I had the perfect excuse to visit Paris for a couple of days (although that was undoubtedly a bonus), but because I was so impressed by the calibre of presentations and new innovations that were showcased from this relatively small meeting. Read more »
In a news release issued by the European Organisation for Rare Diseases (EURORDIS) this week, the society commended the European Medicines Agency (EMEA) in its efforts to make the information that it has available on medicines more patient-friendly. Read more »
Resistance to the social networking revolution has been particularly high amongst pharmaceutical industry professionals, though now it seems that more and more are coming round to the idea. Interestingly, it’s not only the pharma elite that are jumping on the bandwagon; so too are government agencies and, most notably, the FDA. Read more »
Thousands of people, enormous halls separated by mile-long walkways, huge machines promising to deliver efficient, cost-effective solutions, dancing jumpsuit wearers, superheroes, robots, and one pair of very sore feet. This is my first experience of Achema. Read more »
From PharmTech.com